Is GDF15 a Novel Biomarker to Predict the Development of Prediabetes or Diabetes?

Is GDF15 a Novel Biomarker to Predict the Development of Prediabetes or Diabetes?

Bibliographic Details
Main Author:	Kyu Yeon Hur
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2014-12-01
Series:	Diabetes & Metabolism Journal
Online Access:	http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-38-437.pdf

Similar Items

Novel biomarkers for prediabetes, diabetes, and associated complications
by: Dorcely B, et al.
Published: (2017-08-01)

Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19
by: Leticia Alserawan, et al.
Published: (2021-10-01)

GDF-15: A Potential Biomarker and Therapeutic Target in Systemic Lupus Erythematosus
by: Wang-Dong Xu, et al.
Published: (2022-07-01)

The Role of GDF15 as a Myomitokine
by: Kornelia Johann, et al.
Published: (2021-11-01)

Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity
by: Simeng Bu, et al.
Published: (2024-04-01)

The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
by: Philipp Burow, et al.
Published: (2021-09-01)

Supraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15
by: Juli E. Jones, et al.
Published: (2018-03-01)

Evaluation of New Cardiac Damage Biomarkers in Polytrauma: GDF-15, HFABP and uPAR for Predicting Patient Outcomes
by: Aileen Ritter, et al.
Published: (2024-02-01)

Serum growth differentiation factor-15 (GDF-15) is a biomarker of cardiac manifestations in children with COVID-19
by: Sally Raafat Ishak, et al.
Published: (2023-11-01)

TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis
by: Agnė Liuizė (Abramavičiūtė), et al.
Published: (2024-02-01)

GDF-15 predicts cardiovascular events in acute chest pain patients.
by: Stergios Tzikas, et al.
Published: (2017-01-01)

GDF-15 Is Associated with Poor Physical Function in Prefrail Older Adults with Diabetes
by: Reshma Aziz Merchant, et al.
Published: (2023-01-01)

GDF15 as a potential biomarker to distinguish fibrotic from non-fibrotic hypersensitivity pneumonitis
by: A. Alarcon-Dionet, et al.
Published: (2024-01-01)

GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells
by: Chiara Bellio, et al.
Published: (2022-05-01)

Effect of Aerobic and Resistance Training on GDF-15 Levels in Patients with Type 1 Diabetes
by: Yousef Moghaddasi, et al.
Published: (2020-07-01)

Growth differentiation factor-15 (GDF-15) for cardiovascular risk assessment
by: Wiesław Piechota, et al.
Published: (2018-03-01)

Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach
by: Axel C. Carlsson, et al.
Published: (2020-01-01)

Design and Synthesis of AMPK Activators and GDF15 Inducers
by: Meijian Zhang, et al.
Published: (2023-07-01)

TGF-β contamination of purified recombinant GDF15.
by: Oddrun Elise Olsen, et al.
Published: (2017-01-01)

Growth Differentiation Factor-15 (GDF-15) is a Biological Marker in Heart Failure
by: A. M. Alieva, et al.
Published: (2023-01-01)

Pericardial NT-Pro-BNP and GDF-15 as Biomarkers of Atrial Fibrillation and Atrial Matrix Remodeling in Aortic Stenosis
by: Mariana Fragão-Marques, et al.
Published: (2021-08-01)

Imperatorin ameliorates pulmonary fibrosis via GDF15 expression
by: Cheng-Fang Tsai, et al.
Published: (2023-12-01)

GDF15 and Cardiac Cells: Current Concepts and New Insights
by: Luc Rochette, et al.
Published: (2021-08-01)

Role of GDF-15 as an inflammatory marker in patients with psoriasis vulgaris
by: Mustafa Kaan Taşolar, et al.
Published: (2021-12-01)

Growth differentiation factor 15 (GDF15) elevation in children with newly diagnosed cancer
by: Daniel V. Runco, et al.
Published: (2023-12-01)

GDF‐15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD
by: Jiali Wang, et al.
Published: (2023-10-01)

Role of GDF15/MAPK14 Axis in Chondrocyte Senescence as a Novel Senomorphic Agent in Osteoarthritis
by: Weng, Pei-Wei, et al.
Published: (2022)

Role of GDF15/MAPK14 Axis in Chondrocyte Senescence as a Novel Senomorphic Agent in Osteoarthritis
by: Pei-Wei Weng, et al.
Published: (2022-06-01)

GDF15 is a heart‐derived hormone that regulates body growth
by: Ting Wang, et al.
Published: (2017-08-01)

GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome
by: Paisit Kosum, et al.
Published: (2024-03-01)

Prediabetes and the risk of diabetes.
by: McMurray, J, et al.
Published: (2012)

Major Adverse Cardiovascular Events and Mortality Prediction by Circulating GDF-15 in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
by: Suyi Xie, et al.
Published: (2022-07-01)

GDF15 mediates the effects of metformin on body weight and energy balance
by: Coll, A, et al.
Published: (2019)

Research progress on the role and mechanism of GDF15 in body weight regulation
by: Xiao-Chen Dong, et al.
Published: (2023-11-01)

Association between Serum GDF-15 and Cognitive Dysfunction in Hemodialysis Patients
by: Hae Ri Kim, et al.
Published: (2024-02-01)

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
by: Furong Zeng, et al.
Published: (2023-02-01)

GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia
by: Alaa Efat, et al.
Published: (2022-05-01)

Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma
by: Josefin Hidman, et al.
Published: (2023-05-01)

GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans
by: Peter Plomgaard, et al.
Published: (2022-12-01)

Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma
by: Dongliang Yang, et al.
Published: (2023-12-01)